MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
- PMID: 33277324
- PMCID: PMC7775789
- DOI: 10.1126/sciadv.abb6075
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
Abstract
Despite past extensive studies, the mechanisms underlying pulmonary fibrosis (PF) still remain poorly understood. Here, we demonstrated that lungs originating from different types of patients with PF, including coronavirus disease 2019, systemic sclerosis-associated interstitial lung disease, and idiopathic PF, and from mice following bleomycin (BLM)-induced PF are characterized by the altered methyl-CpG-binding domain 2 (MBD2) expression in macrophages. Depletion of Mbd2 in macrophages protected mice against BLM-induced PF. Mbd2 deficiency significantly attenuated transforming growth factor-β1 (TGF-β1) production and reduced M2 macrophage accumulation in the lung following BLM induction. Mechanistically, Mbd2 selectively bound to the Ship promoter in macrophages, by which it repressed Ship expression and enhanced PI3K/Akt signaling to promote the macrophage M2 program. Therefore, intratracheal administration of liposomes loaded with Mbd2 siRNA protected mice from BLM-induced lung injuries and fibrosis. Together, our data support the possibility that MBD2 could be a viable target against PF in clinical settings.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7775789/bin/abb6075-F1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7775789/bin/abb6075-F2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7775789/bin/abb6075-F3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7775789/bin/abb6075-F4.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7775789/bin/abb6075-F5.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7775789/bin/abb6075-F6.gif)
Similar articles
-
IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages.Cell Death Differ. 2021 Apr;28(4):1270-1283. doi: 10.1038/s41418-020-00650-6. Epub 2020 Nov 3. Cell Death Differ. 2021. PMID: 33144678 Free PMC article.
-
The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation.Eur Respir J. 2022 Sep 29;60(3):2003697. doi: 10.1183/13993003.03697-2020. Print 2022 Sep. Eur Respir J. 2022. PMID: 35086828 Free PMC article.
-
Blockade of Mbd2 by siRNA-loaded liposomes protects mice against OVA-induced allergic airway inflammation via repressing M2 macrophage production.Front Immunol. 2022 Aug 25;13:930103. doi: 10.3389/fimmu.2022.930103. eCollection 2022. Front Immunol. 2022. PMID: 36090987 Free PMC article.
-
Inhibiting TGF-[Formula: see text] 1-Mediated Cellular Processes as an Effective Strategy for the Treatment of Pulmonary Fibrosis with Chinese Herbal Medicines.Am J Chin Med. 2021;49(8):1965-1999. doi: 10.1142/S0192415X21500932. Am J Chin Med. 2021. PMID: 34961416 Review.
-
Regulation of alveolar macrophage death in pulmonary fibrosis: a review.Apoptosis. 2023 Dec;28(11-12):1505-1519. doi: 10.1007/s10495-023-01888-4. Epub 2023 Sep 14. Apoptosis. 2023. PMID: 37707713 Free PMC article. Review.
Cited by
-
Macrophage plasticity: signaling pathways, tissue repair, and regeneration.MedComm (2020). 2024 Aug 1;5(8):e658. doi: 10.1002/mco2.658. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39092292 Free PMC article. Review.
-
Persistence of lung structural and functional alterations at one year post-COVID-19 is associated with increased serum PD-L2 levels and altered CD4/CD8 ratio.Immun Inflamm Dis. 2024 Jul;12(7):e1305. doi: 10.1002/iid3.1305. Immun Inflamm Dis. 2024. PMID: 39031504 Free PMC article.
-
Inhibition of OGG1 ameliorates pulmonary fibrosis via preventing M2 macrophage polarization and activating PINK1-mediated mitophagy.Mol Med. 2024 May 31;30(1):72. doi: 10.1186/s10020-024-00843-6. Mol Med. 2024. PMID: 38822247 Free PMC article.
-
Administration of Liposomal-Based Pde3b Gene Therapy Protects Mice Against Collagen-Induced Rheumatoid Arthritis via Modulating Macrophage Polarization.Int J Nanomedicine. 2024 May 17;19:4411-4427. doi: 10.2147/IJN.S454445. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38774028 Free PMC article.
-
Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.Theranostics. 2024 Apr 28;14(7):2794-2815. doi: 10.7150/thno.94482. eCollection 2024. Theranostics. 2024. PMID: 38773984 Free PMC article.
References
-
- Schafer M. J., White T. A., Iijima K., Haak A. J., Ligresti G., Atkinson E. J., Oberg A. L., Birch J., Salmonowicz H., Zhu Y., Mazula D. L., Brooks R. W., Fuhrmann-Stroissnigg H., Pirtskhalava T., Prakash Y. S., Tchkonia T., Robbins P. D., Aubry M. C., Passos J. F., Kirkland J. L., Tschumperlin D. J., Kita H., Le Brasseur N. K., Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun. 8, 14532 (2017). - PMC - PubMed
-
- Raghu G., Behr J., Brown K. K., Egan J. J., Kawut S. M., Flaherty K. R., Martinez F. J., Nathan S. D., Wells A. U., Collard H. R., Costabel U., Richeldi L., de Andrade J., Khalil N., Morrison L. D., Lederer D. J., Shao L., Li X., Pedersen P. S., Montgomery A. B., Chien J. W., O’Riordan T. G.; ARTEMIS-IPF Investigators , Treatment of idiopathic pulmonary fibrosis with ambrisentan: A parallel, randomized trial. Ann. Intern. Med. 158, 641–649 (2013). - PubMed
-
- Shulgina L., Cahn A. P., Chilvers E. R., Parfrey H., Clark A. B., Wilson E. C. F., Twentyman O. P., Davison A. G., Curtin J. J., Crawford M. B., Wilson A. M., Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: A randomised controlled trial. Thorax 68, 155–162 (2013). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous